Immunic reported $-0.24 in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Compugen USD 954K 116K Sep/2025
CSL USD 18M 1000K Dec/2024
Immunic USD -0.24 0.03 Sep/2024
Insmed USD 765K 55K Sep/2024
Quidel USD -1.35 500K Mar/2026
Ultragenyx Pharmaceutical USD 6.51M 649K Dec/2025
United Therapeutics USD 43.2M 3.2M Dec/2025